Early HPV Vaccine Implementation and Uptake in Five Nigerian States

A mixed-methods study of the early rollout of the Human Papillomavirus vaccine in Nigeria in 2023. The research includes quantitative data on vaccine availability and uptake across 52 facilities in five states over four months, supplemented by qualitative interviews with healthcare workers. The dataset was authored by Gbemisola T. Olubayo and last updated in June 2026.

Use Cases

• Analyzing geographic disparities in vaccine availability based on state-level comparisons mentioned in the description
• Modeling factors influencing vaccine uptake based on described contextual determinants like training, trust, and sociocultural barriers
• Evaluating the relationship between facility preparedness and vaccine delivery outcomes as discussed in the qualitative themes

Strengths

• Includes data from 52 health facilities across five Nigerian states (Oyo, Jigawa, Kano, Lagos, and Rivers)
• Combines four months of quantitative availability/uptake data with qualitative interview data from healthcare workers
• Released under a permissive CC-BY-4.0 license

Limitations

• The dataset is a 17.6 KB DOCX file, suggesting limited raw data or a focus on summary findings
• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment for quantitative analysis

Provenance

Source

figshare

Collection Method

Sequential explanatory mixed-methods design involving monthly facility visits, register reviews, and in-depth interviews.

Time Range

Covers a four-month period following the 2023 HPV vaccine introduction in Nigeria.

Freshness

Last updated 2026-06-02 15:40:17; freshness should be verified

Geography

Five Nigerian states: Oyo, Jigawa, Kano, Lagos, and Rivers.